Solalo, Jeraldine V.
HRN: 12-03-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2023
AMPICILLIN 1GM (VIAL)
07/02/2023
07/03/2023
IV
2g
Q6
PROM X 14 Hours
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes